SPAC Tavia Signs LOI with Vita Inclinata, Paving Way for Nasdaq Debut
TAVI is trading near its 52-week low of $9.89 (9.2% above the low).
Summary
Tavia Acquisition Corp. has signed a letter of intent with Vita Inclinata Technologies, a critical step toward completing its business combination and taking the company public on Nasdaq. The deal values Vita at a pre-money enterprise value of $450 million. This follows months of uncertainty after Tavia extended its deadline to March 2027 amid $76.4 million in redemptions and a going concern warning. The sponsor recently provided a $540,000 promissory note to keep operations afloat, underscoring the urgency to close a deal. A definitive agreement and proxy filing will be the next key milestones.
At the time of this announcement, TAVI was trading at $10.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $169.6M. The 52-week trading range was $9.89 to $11.91. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.